Evidence map›Paper›PMID 42738804›Full record

ArticleCells2026

Exploring the Utility of ALDH1 as a Marker for the Cancer Stem Cell Population in OCCC Cell Lines.

Blane Gebreyes, Bart Kolendowski, Yudith Ramos-Valdes, Trevor G Shepherd, Gabriel E DiMattia

Abstract read
In one paragraph

Article in Cells, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Blane GebreyesMary & John Knight Translational Ovarian Cancer Research Unit, Verspeeten Family Cancer Center, London, ON N6A 4L6, Canada.
Bart KolendowskiMary & John Knight Translational Ovarian Cancer Research Unit, Verspeeten Family Cancer Center, London, ON N6A 4L6, Canada.ORCID 0000-0003-0607-5858
Yudith Ramos-ValdesMary & John Knight Translational Ovarian Cancer Research Unit, Verspeeten Family Cancer Center, London, ON N6A 4L6, Canada.
Trevor G ShepherdMary & John Knight Translational Ovarian Cancer Research Unit, Verspeeten Family Cancer Center, London, ON N6A 4L6, Canada.
Gabriel E DiMattiaMary & John Knight Translational Ovarian Cancer Research Unit, Verspeeten Family Cancer Center, London, ON N6A 4L6, Canada.ORCID 0000-0002-2796-9941

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Metastasis, chemoresistance, and tumour recurrence are facilitated by cancer stem cells (CSCs), a small subpopulation of cells capable of regenerating a primary tumour while maintaining the tumour's genetic and phenotypic features. CSCs can be identified by the expression of specific markers; however, the CSC population in ovarian clear cell carcinoma (OCCC), a rare histotype of ovarian cancer, remains poorly defined. Given the well-established role that CSCs play in cancer progression and metastasis, it is critical to identify reliable markers of CSCs in OCCC. Here, we endeavoured to determine whether ALDH1 expression could be used to define OCCC stem cells in OCCC cell lines using a variety of methods including assessing ALDH1A1 expression in spheroids generated under distinct conditions. We also generated and used chemo-resistant cell lines to assess the enrichment of cancer stem cells. Human OCCC cell lines were enriched for CSCs using selective culture conditions and drug resistance methods. CSC-enriched spheroids demonstrated increased expression of stemness markers NANOG and SOX2, while ALDH1A1 expression was enriched only in drug-resistant cell lines, relative to parental cell lines. RNA-seq analyses of CSC-media-derived spheroids versus standard media spheroids provided novel data supporting CSC enrichment and identified transcription factors induced by CSC media. These findings highlight the ambiguous role of ALDH1A1 as a CSC marker in OCCC and demonstrates the utility of CSC enrichment methods for identifying CSC populations in OCCC cell lines.

Indexed as

Aldehyde Dehydrogenase 1 FamilyBiomarkers, TumorNeoplastic Stem CellsOvarian NeoplasmsRetinal DehydrogenaseCell Line, TumorDrug Resistance, NeoplasmFemaleGene Expression Regulation, NeoplasticHumansSpheroids, CellularAldehyde Dehydrogenase 1 FamilyALDH1A1 protein, humanBiomarkers, TumorRetinal DehydrogenaseALDH1A1cancer stem cellschemoresistancemetastasisovarian clear cell carcinomaspheroids

Identifiers

PMID42738804
PMCPMC13565638

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.